Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Study of Ozanimod (RPC1063) in Relapsing Multiple Sclerosis (MS)

ClinicalTrials.gov ID: NCT02294058

Public ClinicalTrials.gov record NCT02294058. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 10:27 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Multi-Center, Randomized, Double-Blind, Double-Dummy, Active Controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of RPC1063 Administered Orally To Relapsing Multiple Sclerosis Patients

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to determine whether ozanimod is effective in the treatment of relapsing multiple sclerosis (RMS).

Study identification

NCT ID
NCT02294058
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Celgene
Industry
Enrollment
1,346 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 55 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 2, 2014
Primary completion
Dec 21, 2016
Completion
Dec 21, 2016
Last update posted
Nov 24, 2020

2014 – 2016

United States locations

U.S. sites
40
U.S. states
22
U.S. cities
38
Facility City State ZIP Site status
Xenosciences Inc Phoenix Arizona 85004
St Josephs Hospital and Medical Center Phoenix Arizona 85013
Northwest Neuro Specialists PLLC Tucson Arizona 85712
Alta Bates Summit Medical Center Berkeley California 94705
Collaborative Neuroscience Network Inc Long Beach California 90806
University of California Davis Medical Center Sacramento California 95817
Multiple Sclerosis Center at UCSF San Francisco California 94158
Denver Neurological Clinic Denver Colorado 80210
Neurology Associates PA Maitland Florida 32751
Neurology Associates of Ormond Beach Ormond Beach Florida 32174
Infinity Clinical Research LLC Pompano Beach Florida 33060
Neurostudies Inc Port Charlotte Florida 33952
Roskamp Institute Sarasota Florida 34243
Axiom Clinical Research of Florida Tampa Florida 33609
Meridien Research Tampa Florida 33634
West Georgia Sleep Disorder Center and Neurology Associates Douglasville Georgia 30134
Consultants In Neurology Northbrook Illinois 60062
University of Kansas Medical Center Kansas City Kansas 66160
MidAmerica Neuroscience Research Foundation Lenexa Kansas 66214
Associates In Neurology Lexington Kentucky 40513
Norton Healthcare Louisville Kentucky 40207
Henry Ford Health System Detroit Michigan 48202
Michigan State University East Lansing Michigan 48824
Minneapolis Clinic of Neurology Golden Valley Minnesota 55422
Washington University St Louis Missouri 63110
Cleveland Clinic Lou Ruvo Center for Brain Health Las Vegas Nevada 89106
Neurology Specialists of Monmouth County PA West Long Branch New Jersey 07764
Neuro Medical Care Associates PLLC Johnson City New York 13790
Raleigh Neurology Associates PA Raleigh North Carolina 27607
Neurology and Neuroscience Associates Inc. Akron Ohio 44320
Neurological Research Institute Inc Columbus Ohio 43221
Providence Multiple Sclerosis Center Portland Oregon 97225
University of Pennsylvania Philadelphia Pennsylvania 19104
Hope Neurology MS Center Knoxville Tennessee 37922
University of Texas Health Science Center at Houston Houston Texas 77030
Bhupesh Dihenia MD PA Lubbock Texas 79410
EvergreenHealth Kirkland Washington 98034
The Polyclinic Seattle Washington 98104
Neurology of Neurosurgery Associates of Tacoma Tacoma Washington 98405
Center for Neurological Disorders Milwaukee Wisconsin 53215

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 184 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02294058, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 24, 2020 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02294058 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →